Based on rat models of type 2 diabetes, researchers found that oral administration of DSF increased insulin levels, improved glucose tolerance and reduced blood glucose and cholesterol levels in diabetic rats (Nagai et al., 2009). The gene discussed is INS; the disease is type 2 diabetes mellitus.